Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.9699
+0.0699 (7.77%)
At close: Nov 28, 2025, 1:00 PM EST
0.9600
-0.0099 (-1.02%)
After-hours: Nov 28, 2025, 4:59 PM EST
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of $23.56 million as of November 28, 2025. Its market cap has decreased by -10.34% in one year.
Market Cap
23.56M
Enterprise Value
6.06M
1-Year Change
-10.34%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from $101.63M to $23.56M, a decrease of -76.82%. That is a compound annual growth rate of -19.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 23.56M | -8.42% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | 121.34M | 39.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |